GSK’s Walmsley On US v. EU COVID-Flu Combos, RSV Branding, And Investing In Infectious Disease

 
• By Sarah Karlin-Smith
  
Vaccine vials with GSK logo in background
GSK executives touted the company’s vaccine plans at the site of its new acquisition Affinivax along BIO 2023. • Source: Shutterstock/Golden Shrimp

More from Vaccines

More from Pink Sheet